ScholarLens Back to search
2021•International Forum of Allergy & RhinologyOpen access

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter W. Hellings, Anju T. Peters, Adam Chaker, Enrico Heffler, Haixin Zhang, Amy Praestgaard, Scott D. Nash, Asif Khan, Shahid Siddiqui, Juby A. Jacob‐Nara, Paul J. Rowe, Yamo Deniz

Open full text 24 citations

Abstract

sponsorship: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Clinical Trials.gov Identifiers: NCT02912468 (SINUS-24) and NCT02898454 (SINUS52). (Sanofi, Regeneron Pharmaceuticals, Inc.)

Open-access reader

About this research paper

What this paper is about

sponsorship: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Clinical Trials.gov Identifiers: NCT02912468 (SINUS-24) and NCT02898454 (SINUS52). (Sanofi, Regeneron Pharmaceuticals, Inc.)

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

sponsorship: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Clinical Trials.gov Identifiers: NCT02912468 (SINUS-24) and NCT02898454 (SINUS52). (Sanofi, Regeneron Pharmaceuticals, Inc.)

Key concepts: Dupilumab, Medicine, Nasal polyps, Chronic rhinosinusitis, Dermatology, Sinusitis, Internal medicine, Immunology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps — Research Paper | ScholarLens